The story has been updated with comments from a conference call held earlier today.

NEW YORK (GenomeWeb News) – Qiagen reported on Sunday a 5 percent increase in third-quarter revenues year over year, paced by the company's consumables sales.

Revenues in the quarter totaled $304.3 million, up from $288.9 million a year ago and beating the consensus Wall Street estimate of $303.8 million. At constant exchange rates (CER), revenues rose 10 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.